{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:36:48Z","timestamp":1790627808644,"version":"4.1.0"},"reference-count":106,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"DOI":"10.5334\/gh.1087","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:33:28Z","timestamp":1643110408000},"page":"6","source":"Crossref","is-referenced-by-count":26,"title":["Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries"],"prefix":"10.5334","volume":"17","author":[{"given":"Eleanor","family":"Bruyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"key20220125063306_B1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1097\/HJH.0000000000002598","article-title":"The use of single-pill combinations as first-line treatment for hypertension: Translating guidelines into clinical practice","volume":"38","year":"2020","journal-title":"Journal of Hypertension"},{"key":"key20220125063306_B2","first-page":"1223","article-title":"2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD","year":"2020","journal-title":"The Lancet (British edition)"},{"key":"key20220125063306_B3","article-title":"Hypertension","author":"World Health Organization (WHO)"},{"key":"key20220125063306_B4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants","volume":"389","author":"NCD Risk Factor Collaboration","year":"2017","journal-title":"Lancet"},{"key":"key20220125063306_B5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","article-title":"The state of hypertension care in 44 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level data from 1.1 million adults","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"key20220125063306_B6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"key20220125063306_B7","article-title":"Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study","volume":"15","year":"2018","journal-title":"PLoS Med"},{"key":"key20220125063306_B8","first-page":"37","article-title":"Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: A systematic review and meta-analysis of randomized controlled trials","year":"2019","journal-title":"Journal of Hypertension"},{"key":"key20220125063306_B9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(19)31629-0","article-title":"Fixed-dose combination antihypertensive medication","volume":"394","year":"2019","journal-title":"The Lancet"},{"key":"key20220125063306_B10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20220125063306_B11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.111.177592","article-title":"Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life ractice","volume":"58","year":"2011","journal-title":"Hypertension"},{"key":"key20220125063306_B12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.112.201566","article-title":"Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: A matched cohort study","volume":"61","year":"2013","journal-title":"Hypertension"},{"key":"key20220125063306_B13","author":"World Health Organization (WHO)","year":"2019"},{"key":"key20220125063306_B14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2471\/BLT.18.222448","article-title":"Comparison of essential medicines lists in 137 countries","volume":"97","year":"2019","journal-title":"Bulletin of the World Health Organization"},{"key":"key20220125063306_B15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/heapol\/czs108","article-title":"Access to medicines from a health system perspective","volume":"28","year":"2013","journal-title":"Health Policy and Planning"},{"key":"key20220125063306_B16","article-title":"The World by Income and Region","author":"The World Bank","year":"2020"},{"key":"key20220125063306_B17","article-title":"Population, total","author":"The World Bank","year":"2019"},{"key":"key20220125063306_B18","author":"The Global Health Observatory","year":"2017"},{"key":"key20220125063306_B19","article-title":"National Essential Medicines Lists (NEMLs) Repository","author":"World Health Organization (WHO)","year":"2019"},{"key":"key20220125063306_B20","article-title":"Where we work","author":"Resolve to Save Lives"},{"key":"key20220125063306_B21","article-title":"Essential Medicines and Health Products Information Portal","author":"World Health Organization (WHO)","year":"2020"},{"key":"key20220125063306_B22","year":"2020"},{"key":"key20220125063306_B23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/ijerph16040605","article-title":"Essential medicines at the national level: The global asthma network\u2019s essential asthma medicines survey 2014","volume":"16","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"key20220125063306_B24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.116.08290","article-title":"Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review","volume":"68","year":"2016","journal-title":"Hypertension"},{"key":"key20220125063306_B25","volume-title":"Guideline for the pharmacological treatment of hypertension in adults","author":"World Health Organization (WHO)","year":"2021"},{"key":"key20220125063306_B26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","year":"2020","journal-title":"Hypertension"},{"key":"key20220125063306_B27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","year":"2018","journal-title":"Journal of Hypertension"},{"key":"key20220125063306_B28","first-page":"579","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"12","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"key20220125063306_B29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jep.12954","article-title":"Evaluation of all African clinical practice guidelines for hypertension: Quality and opportunities for improvement","volume":"25","year":"2019","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"key20220125063306_B30","article-title":"Update Guidelines in Hypertension","year":"2020"},{"key":"key20220125063306_B31","doi-asserted-by":"crossref","first-page":"100899","DOI":"10.1016\/j.pmedr.2019.100899","article-title":"Prevalence of hypertension among office workers in a multi-national company in the Niger-Delta with the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guidelines","volume":"15","year":"2019","journal-title":"Preventive Medicine Reports"},{"key":"key20220125063306_B32","volume-title":"Hypertension care in Ukraine: Breakpoints and implications for action","author":"The World Bank","year":"2018"},{"key":"key20220125063306_B33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jch.13802","article-title":"Asian management of hypertension: Current status, home blood pressure, and specific concerns in Philippines (a country report)","volume":"22","year":"2020","journal-title":"The Journal of Clinical Hypertension"},{"key":"key20220125063306_B34","first-page":"1","volume-title":"Nigerian Hypertension Society Guidelines Committee","year":"2005"},{"key":"key20220125063306_B35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/nmj.NMJ_131_16","article-title":"Antihypertensive medicines prescriptions before and after the Nigeria Hypertension Society guidelines and prescriber\u2019s awareness of the guideline","volume":"58","year":"2017","journal-title":"Nigerian Medical Journal"},{"key":"key20220125063306_B36","volume-title":"WHO model list of essential medicines \u2013 21st list","author":"World Health Organization (WHO)","year":"2019"},{"key":"key20220125063306_B37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5334\/gh.860","article-title":"Implementing fixed dose combination medications for the prevention and control of cardiovascular diseases","volume":"15","year":"2020","journal-title":"Global Heart"},{"key":"key20220125063306_B38","first-page":"115","article-title":"One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects","volume":"4","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"key20220125063306_B39","volume-title":"HEARTS technical package for cardiovascular disease management in primary health care: Access to essential medicines and technology","author":"World Health Organization (WHO)","year":"2018"},{"key":"key20220125063306_B40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12913-019-4140-z","article-title":"Adherence of doctors to hypertension clinical guidelines in academy charity teaching hospital, Khartoum, Sudan","volume":"19","year":"2019","journal-title":"BMC Health Services Research"},{"key":"key20220125063306_B41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.HYP.0000144100.29945.5e","article-title":"Measuring adherence to practice guidelines for the management of hypertension","volume":"44","year":"2004","journal-title":"Hypertension"},{"key":"key20220125063306_B42","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","year":"2019","journal-title":"Circulation Research"},{"key":"key20220125063306_B43","article-title":"Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries","volume":"14","year":"2019","journal-title":"PloS one"},{"key":"key20220125063306_B44","volume-title":"Liste des m\u00e9dicaments","author":"Pharm\u2019Net","year":"2020"},{"key":"key20220125063306_B45","volume-title":"High blood pressure","author":"e-Pharma","year":"2020"},{"key":"key20220125063306_B46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ehj.2014.03.001","article-title":"The Egyptian Hypertension Society: Egyptian Hypertension Guidelines","volume":"66","year":"2014","journal-title":"Egyptian Heart Journal"},{"key":"key20220125063306_B47","volume-title":"Cardiovascular System","author":"Rosheta","year":"2020"},{"key":"key20220125063306_B48","volume-title":"Food Medicine and Healthcare Administration and Control Authority of Ethiopia","author":"World Health Organization (WHO)","year":"2015","edition":"Fifth"},{"key":"key20220125063306_B49","volume-title":"Ethiopian National Guideline on Major NCDs 2016","author":"Ministry of Health","year":"2016"},{"key":"key20220125063306_B50","volume-title":"National Drug Formulary of Ethiopia","author":"Drug Administration and Control Authority of Ethiopia","year":"2007"},{"key":"key20220125063306_B51","first-page":"519","article-title":"Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia","volume":"9","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key20220125063306_B52","volume-title":"Kenya Essentials Medicines List 2019","author":"Ministry of Health","year":"2019"},{"key":"key20220125063306_B53","volume-title":"Kenya National Guidelines For Cardiovascular Diseases Management","author":"Ministry of Health","year":"2018"},{"key":"key20220125063306_B54","volume-title":"Anti-Hypertensives","author":"MYDAWA","year":"2020"},{"key":"key20220125063306_B55","first-page":"12","article-title":"Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study","year":"2020","journal-title":"African Journal of Primary Health Care & Family Medicine"},{"key":"key20220125063306_B56","first-page":"303","article-title":"Generic drugs and the consumption trends of antihypertensives in Morocco","volume":"68","year":"2013","journal-title":"Th\u00e9rapie"},{"key":"key20220125063306_B57","author":"Asset Chemist","year":"2020"},{"key":"key20220125063306_B58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5830\/CVJA-2014-062","article-title":"South African hypertension practice guideline 2014","volume":"25","author":"Hypertension guideline working group","year":"2014","journal-title":"Cardiovascular Journal of Africa"},{"key":"key20220125063306_B59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/20786190.2014.953868","article-title":"An overview of fixed-dose combinations of antihypertensive drugs in South Africa","volume":"56","year":"2014","journal-title":"South African Family Practice"},{"key":"key20220125063306_B60","volume-title":"National Essential Medicines List","author":"Federal Ministry of Health","year":"2014"},{"key":"key20220125063306_B61","volume-title":"Sudan National Standard Treatment Guidelines","author":"Federal Ministry of Health","year":"2014"},{"key":"key20220125063306_B62","author":"The Ministry of Health CD, Gender, Elderly and Children","year":"2017","journal-title":"Standard Treatment Guidelines & National Essential Medicines List Tanzania Mainland"},{"key":"key20220125063306_B63","first-page":"11","article-title":"Prescribing patterns and cost of antihypertensive drugs in private hospitals in Dar es Salaam, Tanzania","year":"2009","journal-title":"East and Central African Journal of Pharmaceutical Sciences"},{"key":"key20220125063306_B64","volume-title":"Uganda Clinical Guidelines 2016: National Guidelines for Management of Common Conditions","author":"Ministry of Health","year":"2016"},{"key":"key20220125063306_B65","volume-title":"Tablets and capsules","author":"PinePharmacy","year":"2020"},{"key":"key20220125063306_B66","volume-title":"National Standard Treatment Guidelines for the Primary Level","author":"Ministry of Public Health of the Islamic Republic of Afghanistan","year":"2013"},{"key":"key20220125063306_B67","author":"Ministry of Public Health, General Directorate of Pharmaceutical Affairs, Avicenna Pharmaceutical Institute","year":"2014","journal-title":"National Essential Medicines List of Afghanistan"},{"key":"key20220125063306_B68","author":"Directorate General of Health Services MoHaFA","year":"2013"},{"key":"key20220125063306_B69","author":"BanglaMeds","year":"2020"},{"key":"key20220125063306_B70","first-page":"182","article-title":"2018 Chinese guidelines for prevention and treatment of hypertension \u2013 a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension","volume":"16","author":"Joint Committee for Guideline Revision","year":"2019","journal-title":"Journal of Geriatric Cardiology"},{"key":"key20220125063306_B71","author":"Tpl","year":"2020"},{"key":"key20220125063306_B72","volume-title":"Standard Treatment Guidelines \u2013 Hypertension","author":"Ministry of Health & Family Welfare","year":"2015"},{"key":"key20220125063306_B73","first-page":"5","article-title":"Assessment of rational use of fixed dose combinations in hypertension in a tertiary care teaching hospital in north India","year":"2018","journal-title":"International Journal of Advances in Medicine"},{"key":"key20220125063306_B74","volume-title":"Search results for Hydrochlorothiazide","author":"Medlife","year":"2020"},{"key":"key20220125063306_B75","author":"Indonesian Society of Hypertension","year":"2019"},{"key":"key20220125063306_B76","first-page":"603","article-title":"Optimization of blood pressure treatment with fixed-combination perindopril\/amlodipine in patients with arterial hypertension","volume":"32","year":"2012","journal-title":"Clinical Drug Investigation"},{"key":"key20220125063306_B77","volume-title":"Product Kategori: Sistem Kardiovaskuler & Hematopoietik","author":"K24Klik","year":"2020"},{"key":"key20220125063306_B78","volume-title":"Hypertension, Heart & Artery Disease","author":"My-Medicine","year":"2020"},{"key":"key20220125063306_B79","volume-title":"3rd National Hypertension Guideline: For the prevention, detection, evaluation & management of hypertension","author":"Pakistan Hypertension League","year":"2018"},{"key":"key20220125063306_B80","volume-title":"Prescription Drugs","author":"MedOnline","year":"2020"},{"key":"key20220125063306_B81","volume-title":"Rose Pharmacy Generics","author":"RosePharmacy","year":"2020"},{"key":"key20220125063306_B82","author":"Thai Hypertension Society","year":"2019","journal-title":"2019 Thai Guidelines on The Treatment of Hypertension"},{"key":"key20220125063306_B83","first-page":"308","article-title":"Management of hypertension in the general practice clinic: Post-marketing surveillance with a fixed combination of perindopril and indapamide","volume":"24","year":"2009","journal-title":"Srinagarind Medical Journal"},{"key":"key20220125063306_B84","volume-title":"Hypertension diagnosis and treatment guidelines 2018","year":"2018"},{"key":"key20220125063306_B85","volume-title":"Thuc huyt \u00e1p- tim mch, thuc li tiu","author":"JioHealth","year":"2020"},{"key":"key20220125063306_B86","volume-title":"National List of Essential Medicines","author":"Cabinet Ministers of Ukraine","year":"2017"},{"key":"key20220125063306_B87","first-page":"66","article-title":"Pharmacoeconomic evaluation of fixed-dose triple combination for antihypertensive therapy in Ukraine","volume":"1","year":"2014","journal-title":"Journal of Health Policy and Outcomes Research"},{"key":"key20220125063306_B88","doi-asserted-by":"crossref","first-page":"PA279","DOI":"10.1016\/j.jval.2013.03.1447","article-title":"Evaluation the feasibility of some schemes of antihypertensive therapy on the budget impact analysis and missed opportunities analysis in Ukraine","volume":"16","year":"2013","journal-title":"Value in Health"},{"key":"key20220125063306_B89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.26442\/2075082X.2019.1.190179","article-title":"Z, on behalf of the experts. Clinical guidelines: Diagnosis and treatment of arterial hypertension","volume":"16","year":"2019","journal-title":"Systemic Hypertension"},{"key":"key20220125063306_B90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13690-019-0366-9","article-title":"Adherence to antihypertensive medication in Russia: A scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017","volume":"77","year":"2019","journal-title":"Arch Public Health"},{"key":"key20220125063306_B91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEOR.S251721","article-title":"Analysis of preferences in the use of fixed-doses combinations antihypertensive drugs in the regions of far-eastern federal district","volume":"12","year":"2020","journal-title":"ClinicoEconomics and Outcomes Research"},{"key":"key20220125063306_B92","article-title":"Consenso Argentino de Hipertensi\u00f3n Arterial","author":"Sociedad Argentina de Hipertensi\u00f3n Arterial","year":"2018"},{"key":"key20220125063306_B93","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jch.13830","article-title":"Adherence to antihypertensive drug treatment in Argentina: A multicenter study","volume":"22","year":"2020","journal-title":"The Journal of Clinical Hypertension"},{"key":"key20220125063306_B94","volume-title":"Resultados: Valsartan","author":"Farmacity","year":"2020"},{"key":"key20220125063306_B95","volume-title":"7th Brazilian Guideline of Arterial Hypertension","author":"Arquivos Brasileiros de Cardiologia","year":"2016"},{"key":"key20220125063306_B96","first-page":"8s","article-title":"Access to and use of high blood pressure medications in Brazil","volume":"50","year":"2016","journal-title":"Rev Saude Publica"},{"key":"key20220125063306_B97","volume-title":"Press\u00e3o Alta","author":"Ultrafarma","year":"2020"},{"key":"key20220125063306_B98","volume-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica: Para el manejo de la hipertensi\u00f3n arterial primaria","author":"Gobierno de Colombia","year":"2017"},{"key":"key20220125063306_B99","volume-title":"Cardiovasculares","year":"2020"},{"key":"key20220125063306_B100","volume-title":"Diagnostico y Tramtamiento de la Hipertension arterial en el Primer nivel de atencion","author":"Centro Nacional de Excelencia Tecnologica en Salud","year":"2014"},{"key":"key20220125063306_B101","volume-title":"Results for: \u2018hydrochlorothiazide\u2019","author":"MEXI Pharmacy","year":"2020"},{"key":"key20220125063306_B102","first-page":"97","article-title":"The first Iranian recommendations on prevention, evaluation and management of high blood pressure","volume":"8","author":"Group FRoHBPW","year":"2012","journal-title":"ARYA Atheroscler"},{"key":"key20220125063306_B103","year":"2012"},{"key":"key20220125063306_B104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/jpbs.JPBS_82_19","article-title":"Evaluation of blood pressure control and associated factors among patients with hypertension in Iraq: A prospective cross-sectional study","volume":"11","year":"2019","journal-title":"J Pharm Bioallied Sci"},{"key":"key20220125063306_B105","first-page":"535","article-title":"2019 Turkish Hypertension Consensus Report","volume":"47","year":"2019","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"key":"key20220125063306_B106","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00228-007-0266-8","article-title":"Prescribing pattern of antihypertensive drugs in primary care units in Turkey: Results from the TURKSAHA study","volume":"63","year":"2007","journal-title":"European Journal of Clinical Pharmacology"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/doi.org\/10.5334\/gh.1087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:22:16Z","timestamp":1657531336000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.5334\/gh.1087\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.5334\/gh.1087","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}